Salwa A Elgebaly
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2024First federal award
$3.6MFederal grants as PI3 awards
2Patents grantedLatest Sep 19, 2023
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $3.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 29, 2025 | NIH | SBIR Phase II Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart Utilization | $1.9M | NOUR HEART, INC. |
| Jan 16, 2025 | NIH | SBIR Phase II Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart Utilization | $50K | NOUR HEART, INC. |
| Sep 18, 2024 | NIH | SBIR Phase II Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart Utilization | $1.7M | NOUR HEART, INC. |
3 patents as inventor
- US 11654134NOUR HEART, INC.May 23, 2023
- US 11761966NOUR HEART, INC.Sep 19, 2023
- US NOUR HEART, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#464
Awards as PI#822
Patents#102
Companies
- NOUR HEART, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.